BioCryst Pharmaceuticals BCRX Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's gross profit?
- BioCryst Pharmaceuticals (BCRX) reported gross profit of $151.04M in Q1 2026.
- How has BioCryst Pharmaceuticals's gross profit changed year-over-year?
- BioCryst Pharmaceuticals's gross profit increased by 7.1% year-over-year, from $140.97M to $151.04M.
- What is the long-term trend for BioCryst Pharmaceuticals's gross profit?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's gross profit has grown at a 54.6% compound annual growth rate (CAGR), from $149.94M to $855.76M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.